In contrast, CD4 + CD25 + T cells were more in the patient group than in healthy controls (P < 0.01) on both days 14 and 25. There were fewer CD3 + CD4 + /CD3 + CD8 + cells in the patient group than in the healthy control group on day 25 (P < 0.05). Less proliferation and lower levels of IL-2 and IFN-c were also observed in the patient group compared with the control group (P < 0.05).These data suggest that HBV DNA infected and integrated into the BM HSCs from patients with chronic HBV infection and that these BM HSCs generated defective T cells.
HBV infection patients. T cells were generated by coculturing the HSCs with delta-like ligand 1-expressing OP9 (OP9-DL1) cells. The phenotypes of the T cells were then evaluated by flow cytometric (FACS) analysis on days 14 
INTRODUCTION
Patients with chronic HBV infection show immune tolerance, which has been attributed to the poor T-cell responses in the peripheral blood [1] [2] [3] [4] . However, few studies have investigated whether differentiation of T cells from HSCs is associated with a weak T-cell response in chronic HBV infection. Ilan et al. reported that bone marrow transplantation led to the ablation of persistent hepatitis B, as immune reconstitution of the recipient's bone marrow resulted in clearance of both circulating HBsAg and e HBV DNA [5] . Few reports demonstrated the development of immunity against HBV after stem cell transplantation [6] . Furthermore, some studies have reported seroconversion in chronic hepatitis B infection after stem cell transplantation [7, 8] . These studies implied [11] . However, ZunigaPflucker and his fellow researchers discovered that when murine hematopoietic precursor cells (HPC) were cocultured with delta-like ligand 1 (OP9-DL1) cells in the presence of IL-7 and Flt3L, these cells differentiated into double-positive (DP) cells and finally into mature CD3 + T cells that were able to produce IFN-c [12] . T cells could also be generated from various sources of human hematopoietic precursors including human bone marrow CD34 + hematopoietic cells in OP9-DL1 cultures [13] [14] [15] . Van Coppernolle et al. suggested that the generation of T cells by the OP9-DL1 system may be dependent on positive selection mechanisms similar to those operative in the thymus [16] . This OP9-DL1 system also has the capacity to generate regulatory T cells (Tregs) [17] . Our goal was to study T cells generated from CD34 + BM HSCs from chronic HBV infection patient, and the OP9-DL1 system constituted a simple and convenient approach for generating T lymphocytes in vitro. Chronic HBV infection can lead to cirrhosis and hepatocellular carcinoma. Although antiviral therapy has improved dramatically in the last few years, it still cannot be produce a cure. Consequently, the persistent poor immune responses are an important factor. Thus, our investigation will provide a theoretical basis for immune tolerance in patients with chronic HBV infection. Step RT-PCR kit (QIAGEN) protocol. For the HB S gene mRNA detection, the following HB S gene-specific primers were used: forward(fw), 5′-TATCGCTGGATGTGTCTG C-3′; reverse, 5′-AGACTTGG CCCCCAATACC-3′ which amplified a 403-bp region as used by Huang and Li X-M et al. [18] . To ensure that the amplified HB S gene bands originated from cDNA from the patients' HSC, the total RNA from the negative controls (healthy HSC) was amplified at same time. For GAPDH, the following primers were used: fw, 5-TGCAC CACCAACTGCTTAGC-3 and GAPDH; rev, 5-GGCATG GAC TGTGGTCATGAG-3 [19] . In these experiments, GAPDH was used as an internal control gene to normalize the amount of RNA loaded for each sample. The genes were amplified using 5 lL of cDNA as template. A total of 10 lL of each RT-PCR product was made visible by staining with ethidium bromide, after electrophoresis on 1% agarose gel. The HBsAg secreted in the coculture supernatants of the two groups of subjects was measured using the Roche Elecsys HBsAg kit (Roche, Basel, Switzerland) according to the manufacturer's protocols on day 0, day 14 and day 25.
PATIENT AND METHODS

Patients
Fluorescence in situ hybridization (FISH)
FISH was performed according to Wang [20] . In our study, material from three sources was examined; CD34 The samples were treated with 0.01 M PBS for 10 min at room temperature and then with 200 lg/mL pepsin for 10 min, followed by 2 min each in 70%, 80%, 95% and 100% ethanol. The samples were denatured at 75°C for 4 min in 73% formamide in 2 9 SSC, and 40 lL of HBV DNA probe (Tbd science Biotechnology, Tianjin, China) was then added. The samples with the probe were incubated for 8-16 h in a dark moist chamber at 37°C. Subsequently, the slides were washed for 5 min each in 2 9 SSC, 0.2 9 SSC and 0.1 M TBS at 37°C. FITC compound (Tbd science Biotechnology) was dropped onto slides to fluorescently label the HBV DNA probe for 2 h. The nuclei and chromosomes were counterstained with 5 lL DAPI for 5 min. The slides were analysed by an Olympus BX61 fluorescent microscope, and images were acquired with 3.93 image analysis software (Olympus, Tokyo, Japan)
CD34 + BM HSCs and OP9-DL1 cocultures
The coculture experiments followed the method of Z uñiga-Pfl€ ucker et al. [21] . OP9-DL1 cells were obtained from Dr. J. C. Zuniga-Pflucker (University of Toronto, Toronto, Canada). In this study, two groups were investigated; a CHB patient group and a healthy control group. A total of 1 9 10 3 OP9-DL1 cells were seeded onto 12-well tissue culture plates (Boster Bio, Wuhan, China) 24 h before the experiment. Sorted CD34 + BM HSCs from the two groups were then seeded, respectively, at 2 9 10 5 cells/well into 12-well plates containing a subconfluent monolayer of OP9-DL1 cells. All coculture experiments were performed in culture medium consisting of IMDM (GIBCO, Carlsbad, CA, USA) supplemented with 20% FCS (GIBCO, Grand
Island, NY, USA), 100 IU/mL streptomycin, penicillin and L-glutamine in the presence of 5 ng/mL IL-7 (BD Biosciences), 5 ng/mL Flt3L (BD Biosciences) and 2.5 ng/mL stem cell factor (SCF) (BD Biosciences). Every 4-5 days, the cells were harvested by forceful pipetting and transferred onto a fresh confluent monolayer of OP9-DL1 cells. Fresh culture medium was then added while the aforesaid cytokine was added again. The cocultures were maintained for 25 days for the generation of T cells.
T-cell expansion and detection of T-cell subpopulations
The T cells were, respectively, harvested from the OP9-DL1 cocultures on day 14 and day 25, and the T-cell phenotype was studied using CD3 
T-lymphocyte proliferation and cytokine production assays
Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a fluorescent dye used to label cells, the proliferative activity of which can then be detected by flow cytometry. Using this method, cells may be traced through successive generations without the use of radioactivity [22] . CFSE dilution was measured by flow cytometry for assessing T-lymphocyte proliferation. Labelling of T cells with CFSE has been described previously [23] . T cells from the patient group and healthy controls were harvested from OP9-DL1 cocultures on day 25 were incubated with CFSE (Invitrogen, Carlsbad, CA, USA) in 10 mM/L PBS at 37°C for 15 min. The cell labelling was terminated by addition of one-tenth the volume of FCS. Cells were then washed twice in 37°C PBS for 10 min and suspended at 2 9 10 6 cells/mL, and half of the CFSE-labelled T cells were then cultured and stimulated with 5 lg/mL phytohemagglutinin (PHA) for 72 h. The rest of the cells were cultured without PHA. Following the 72-h incubation, the percentage of decreased fluorescence intensity of the PHA-stimulated and non-PHA-stimulated cells was analysed by FACS. The cell division index (CDI) is the ratio of percentage of decreased fluorescence intensity of the PHA-stimulated to non-PHAstimulated cells, which was used to calculate cell proliferation dynamics. The culture supernatants of lymphocytes stimulated with PHA for 72 h were collected and frozen for analysis of IL2 and IFN-c levels. The lymphocyte culture supernatant was analysed for cytokine content by IL-2 and IFN-c specific ELISA kits as recommended by the manufacturer (Anke Bio, Beijing, China) and described previously [24] .
RESULTS
RT-PCR and HBsAg quantitation
RT-PCR for HB S gene-specific RNA was shown to be reliable for detecting HBV gene(s) expression. The 403-bp RT-PCR product corresponding to the amplified HB S gene fragment was detected in CD34 + HSCs from all patients by agarose gel electrophoresis, but no expression of these gene fragments was observed in the HSCs from the healthy controls (Fig. 1) . These results demonstrated that HB S encoding mRNAs are expressed in the CD34 + BM HSCs from patients.
The results showed that no HBsAg was detected on day 0. However, HBsAg quantitation indicated levels of 65.43 AE 8.21 ng/mL on day 14 and 89.35 AE 13.04 ng/ mL on day 25 in the patient group. No HBsAg was detected on days 0, 14 and 25 in the healthy control group.
Fluorescence in situ hybridization
To perform FISH, HB S gene fragments were used as a specific probe. Positive and green fluorescent signals were observed in the nucleus of CD34 + HSCs from all the patients and chromosomes of five of the patients (Fig. 2a,  d , d*), as well as in the nucleus and chromosomes of HepG2.2.15 cells (Fig. 2b, e, e*) . No Positive signals were detected in the healthy controls (Fig. 2c, f) .
Phenotypic analysis of T lymphocytes
T lymphocytes were generated in OP9-DL1 cultures. Fig. 3a, b, c) . However, the frequencies of the CD3 + CD8 + subsets were similar in the patient group (9.59 AE 2.40%) and in the healthy controls (12.30 AE 2.05%) (P > 0.05; Fig. 3d ). In contrast, the frequencies of CD4 + CD25 + T cells were higher in the patient (5.15 AE 1.22%) than in the healthy control group (1.82 AE 0.39%) (P < 0.05; Fig. 3e ). On day 25, the frequencies of CD3 + CD4 + T cells in the patient (22.67 AE 4.03%) also were lower than in the healthy control group (44.98 AE 5.96%) (P < 0.01; Fig. 3c ) while the frequency of CD3 + TCRab + T cells in the patient (57.98 AE 1.95%) was even lower than in the healthy control group (72.35 AE 1.70%) (P < 0.001; Fig. 3a) . The CD4 + CD8 + expression in the patient (5.66 AE 1.14%) was also lower than in healthy controls group (10.26 AE 1.52%) (P < 0.05; Fig. 3b) 
CDI and cytokines produced by T lymphocytes
The fluorescence intensity of the CFSE-labelled HSCs was remarkably decreased in the healthy control group ( Fig. 4b ) than in the patient group (Fig. 4a) T-cell development is usually divided into three stages; double negative (DN), double positive (DP) and single positive (SP) [25] . The DP cell is an immature T cell expressing CD4 + CD8 + , but the SP cell is a mature T cell expressing P-values were determined using Student's t test. (*P < 0.05, **P < 0.01,***P < 0.001, # P > 0.05).
viewpoint that abnormal expression of T-cell phenotype could be present in both the mature and immature stage of development and that differentiation and development of these T-cell subsets become more and more disproportional over time. [30] . Furthermore, there is a standpoint that the functionality of HBV-specific CD8 T cells is more important than the number of T cells to control HBV replication [31] . Analysing the data in ours and previous studies, we assumed that the number of CD8 + T cells was not significantly different in the stage of T-cell development until entering the blood circulation. Cytokines modulate the host immune response to infectious microorganisms such as interferon gamma (IFN-c) and interleukin (IL-2). These play a key role in cell-mediated immune responses against bacteria, fungi and viruses [32] . Therefore, IL-2 and IFN-c production was also measured. The lower IFN-c and IL-2 production and reduced proliferation in the patient group indicated that both the T-cell phenotype and function were defective in the patient group. Down-regulation of CD3 + CD4 + and CD3 + TCRab + and up-regulation of CD4 + CD25 + inhibited antigen recognition, presentation and activation of T cells. Therefore, the defective T-cell phenotype expression is an important factor of immune tolerance in patients with chronic HBV infection. Why does the phonotype and function of the T cells in the patient group become abnormal? There are two possible reasons. Firstly, some HBV DNA gene segments as exogenous sequences are irregularly integrated into the HSCs DNA, which could lead to gene rearrangements in HSCs. Therefore, the HSCs with chromosomal variation could cause differentiation into abnormal lymphatic progenitor cells, and this process could interact with the gene rearrangement of TCRab T cells. Some studies have also reported that HBV DNA integration in hepatocytes is a causal risk factor for primary liver cancer [33] . Another report demonstrated that both HB S and pre-C/C coding genes are integrated into embryos [34] . Moreover, continual expression of HBsAg because of replication and integration of HBV DNA in HSCs could affect positive and negative selection during T-cell development, which could lead to abnormal expression of T-cell phenotype or apoptosis of some T-cell subpopulations. Accordingly, we presumed that T-cell defects associated with CHB infection could be improved by hematopoietic stem cell transplantation, similar to the aforementioned reports. Mesenchymal hematopoietic stem cell transplantation has gained a great deal of attention in the last few years because of its ability to improve liver function in patients with liver failure, caused by hepatitis B [35] . However, this treatment is rarely used for immune reconstitution against hepatitis B virus. In the immune tolerance phase of HBV, the immune system does not recognize virus, so there is no attack and no damage by the immune system. According to the 2010 American Association for Study of Liver Disease (AALSD) guidelines, patients in this phase do not need antiviral treatment. However, these individuals are still a source of infection and are at risk of disease progression. However, hematopoietic stem cell transplantation (HSCT) would likely remove HBV and cause HBsAg seroconversion in these patients. In recent years, autologous hematopoietic stem cell transplantation (AHSCT) has gained attention, because this therapy does not cause graft versus host disease (GVHD) and does not require a donor. However, according to our results, immune reconstruction is unlikely to be acquired after AHSCT in chronic HBV infection patients, because the HSCs would generate defective T cell following infection and integration of HBV DNA. Therefore, allogeneic hematopoietic stem cell transplantation could be more suitable than AHS-CT. However, it is not clear whether the elimination of HBV DNA in the BM HSCs can restore normal differentiation of HSCs in patients.
In conclusion, we have shown that the HSCs of chronically HBV-infected patients with integrated HBV DNA generated defective T cells, because of the effect on differentiation and development of T lymphocytes. This suggestion has provided a theoretical basis for the use of hematopoietic stem cell transplantation as a therapy for chronically HBV-infected patients.
